Biocon has had a spectacular third quarter. Its consolidated revenues for the period have surged 15%, and this has helped net profit jump 25%. CNBC-TV18's Vineetha Athrey finds out what Biocon's doing right, and what lies ahead.
first published: Jan 20, 2011 09:20 pm
A collection of the most-viewed Moneycontrol videos.
You are already a Moneycontrol Pro user.

